SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $6,546,000 | -15.9% | 130,000 | 0.0% | 0.24% | -25.7% |
Q2 2018 | $7,781,000 | +30.7% | 130,000 | 0.0% | 0.32% | +15.8% |
Q1 2018 | $5,954,000 | +14.9% | 130,000 | 0.0% | 0.28% | +3.3% |
Q4 2017 | $5,181,000 | -0.4% | 130,000 | 0.0% | 0.27% | -8.5% |
Q3 2017 | $5,200,000 | -28.6% | 130,000 | -23.1% | 0.30% | -34.9% |
Q2 2017 | $7,284,000 | -37.1% | 169,000 | -54.3% | 0.45% | -40.9% |
Q1 2017 | $11,581,000 | +3.1% | 370,000 | -16.9% | 0.77% | +4.9% |
Q4 2016 | $11,236,000 | +2.1% | 445,000 | 0.0% | 0.73% | +8.8% |
Q3 2016 | $11,005,000 | -6.0% | 445,000 | -22.6% | 0.67% | -6.3% |
Q2 2016 | $11,713,000 | +33.6% | 575,000 | 0.0% | 0.72% | +46.3% |
Q1 2016 | $8,769,000 | +31.0% | 575,000 | +15.5% | 0.49% | +46.3% |
Q4 2015 | $6,693,000 | +36.8% | 498,000 | +42.9% | 0.34% | +18.0% |
Q3 2015 | $4,891,000 | +0.5% | 348,600 | +21.6% | 0.28% | +8.0% |
Q2 2015 | $4,866,000 | +40.4% | 286,600 | 0.0% | 0.26% | +0.8% |
Q1 2015 | $3,465,000 | +62.4% | 286,600 | +11.5% | 0.26% | +12.0% |
Q4 2014 | $2,133,000 | -4.5% | 257,000 | 0.0% | 0.23% | -25.3% |
Q3 2014 | $2,233,000 | -15.3% | 257,000 | +6.8% | 0.31% | -12.8% |
Q2 2014 | $2,635,000 | +36.7% | 240,600 | +11.6% | 0.36% | +19.7% |
Q1 2014 | $1,927,000 | – | 215,500 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |